For people who've plateaued on tirzepatide or semaglutide, one of the most proof-based up coming move in 2026 is optimizing the current protocol. Modifying dose timing, revisiting macronutrient distribution, or incorporating resistance education to maintain lean mass during continued weight loss.This isn't just a chart; it is a framework for threat